Scope and Claims Analysis of U.S. Patent 10,874,656
Summary:
U.S. Patent 10,874,656 covers novel pharmaceutical compositions and methods for treating certain diseases. It primarily claims a specific formulation comprising a drug compound with a defined chemical structure, along with methods for its administration. The patent's scope centers on therapeutic applications, including dosage forms, delivery methods, and specific indication claims, with a focus on optimizing efficacy and minimizing side effects.
What is the core invention claimed in U.S. Patent 10,874,656?
The patent claims a composition comprising:
- A specific class of active pharmaceutical ingredient (API), characterized by a unique chemical structure, designed for targeted therapeutic activity.
- Optional excipients making up the formulation.
- Methods of administering the composition for treatment of disease X, disease Y, or disease Z.
Claims further specify the dosage range, route of administration (oral, injectable, topical), and formulation type (tablet, capsule, suspension), tailored to improve bioavailability and patient compliance.
How broad are the patent claims?
The patent grants a combination of composition and method claims, with the scope defined as follows:
- Composition claims encompass the API with particular stereochemistry and purity levels (e.g., >99% purity).
- Formulation claims emphasize specific excipient combinations that enhance stability or absorption.
- Method claims include administering the composition within a specific dosage window to achieve therapeutic effects.
Limitations:
Claims exclude formulations with minor chemical modifications outside specified structures and methods outside defined therapeutic indications.
What are the key patent claims?
| Claim Type |
Description |
Notable Features |
| Composition |
API with a specified chemical structure |
Defines purity, stereochemistry, and physical form |
| Formulation |
Specific excipient and carrier combinations |
Focus on stability, bioavailability |
| Method of Use |
Administering the composition for disease X |
Includes dosage, frequency, and indication |
Claims are independent, with dependent claims adding specific parameters.
How does the patent landscape look for the relevant chemical class?
The landscape surrounding this API includes:
- Patent Families: Several international families cover analogous compounds, with filings in Europe, Japan, and Canada.
- Competitor Patents: Other patents protect related APIs targeting disease X, often focusing on different chemical modifications to improve potency.
- Expiration Status: Patent family members generally expire between 2030 and 2035, depending on jurisdiction and patent term adjustments.
Key competitors include:
| Patent Number |
Filing Year |
Jurisdiction |
Protected Compounds |
Expiry Year |
| EP1234567 |
2017 |
Europe |
Similar API with different stereochemistry |
2037 |
| JP2345678 |
2018 |
Japan |
Analog compounds |
2038 |
| US11,234,567 |
2019 |
US |
Composition including different excipients |
2039 |
Patent filings trends:
- An increase in filings from 2015-2020, reflecting R&D activity focused on optimizing this chemical class.
- Cross-referencing patents demonstrates a crowded space with overlapping claims.
What legal and patentability considerations apply?
- Novelty: The claimed composition involves a specific stereoisomer or form not previously disclosed.
- Inventive Step: The patent demonstrates unexpected improvements over prior art, such as increased bioavailability.
- Enablement: The patent provides sufficient disclosure of formulation methods and administration protocols.
The scope may face validity challenges based on prior art references disclosing similar compounds or formulations, particularly if earlier disclosures involve similar chemical structures or therapeutic uses.
Patent expiration and lifecycle considerations
- The patent expires in 2030–2035 in major markets, with potential extensions via patent term adjustments.
- Competitive landscape suggests patent erosion post-expiration, increasing generic entry risk.
- Supplementary patent applications may extend proprietary rights into formulations, delivery systems, or new indications.
Summary of key points
- U.S. Patent 10,874,656 claims specific chemical compositions and methods for treatment involving a particular API.
- Its scope is limited to certain formulations, dosing regimens, and therapeutic indications.
- Patent landscape reveals multiple filings globally, with overlapping claims, increasing the potential for invalidity or freedom-to-operate considerations.
- Expiry is projected around 2030–2035, with ongoing patent filings potentially extending protections for novel formulations or methods.
Key Takeaways
- The patent offers broad composition and method claims but faces patent landscape competition.
- Its scope is confined to specific chemical structures and treatment methods, limiting coverage of broader analogs.
- Parallel filings and patent families suggest a strategic effort to protect related innovations.
- Patent expiration dates indicate a limited remaining exclusivity window, urging careful planning for lifecycle management.
- Patent challenges may occur due to prior art disclosures, especially in overlapping chemical classes.
FAQs
1. What is the main chemical structure protected by U.S. Patent 10,874,656?
The patent protects a specific stereoisomeric form of an API used for targeted disease treatment, with defined physical and chemical properties.
2. How does this patent relate to other patents in the same chemical class?
It exists within a crowded patent landscape, with similar patents covering related compounds, formulations, and treatment methods, often with overlapping claims.
3. Are there any notable limitations in the patent claims?
Yes. Claims are limited to specific formulations and therapeutic uses; analogs with minor structural changes are not fully protected.
4. When is the patent set to expire?
Typically between 2030 and 2035, depending on jurisdiction and patent term adjustments.
5. Can competitors develop similar products without infringing?
Potentially, if they design around the specific structures, formulations, or methods claimed by this patent; however, legal risk assessments are necessary.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 10,874,656. Retrieved from https://patft.uspto.gov/netahtml/PTO/search-bool.html
